TapewireFind a company

person · Reporting owner

DART KENNETH BRYAN

Disclosed activity across 5 companies

Tapewire entity
21577
SEC CIK
0001331271

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Flutter Entertainment plcFLUT · Entity 133010% ownerAugust 17, 2026August 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Flutter Entertainment plc

Report date August 17, 2026 · Filed August 19, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Total Return SwapSEC Table II · derivative / convertible security · Expires 2028-03-02IndirectSee footnote21,883,047 Reported balance After 2026-08-17 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-08-17 · Purchase · Acquired 85,899 · Balance 21,883,047

F1: The reference price for the Swap is $97.2418 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i) the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on OBFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2: Lake Michigan Limited is the party to the reported transaction and direct "holder" of the "notional" shares. Lake Michigan Limited and LBS Limited were parties to previously reported swap transactions that provide an aggregate position in 21,797,148 "notional" shares. As owner of LBS Limited and Lake Michigan Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The reference price for the Swap is $97.2418 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i) the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on OBFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2: Lake Michigan Limited is the party to the reported transaction and direct "holder" of the "notional" shares. Lake Michigan Limited and LBS Limited were parties to previously reported swap transactions that provide an aggregate position in 21,797,148 "notional" shares. As owner of LBS Limited and Lake Michigan Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Avid Bioservices, Inc.

Report date September 11, 2017 · Filed September 29, 2017

Jointly reported with Eastern Capital LTD, Portfolio Services Ltd.

Section 16 reporting ended · disclosed 2017-09-29. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,777,183 Reported balance Holding disclosure · report date 2017-09-11 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 3,777,183

10.5% Series E Convertible Preferred StockSEC Table II · derivative / convertible securityDirect440,000 Reported balance Holding disclosure · report date 2017-09-11 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 440,000

F1: Each share of Series E Preferred Stock is convertible at any time at the option of the Reporting Persons into the number of whole shares of the Issuer's common stock which is equal to $25.00 per share, plus accrued and unpaid dividends, divided by a conversion price of $21.00. In the event of a change of control (as further described in the certificate of designation of rights and preferences for the Series E Preferred Stock, or Certificate of Designations, filed as Exhibit 3.11 to the Company's Form 8-A filed with the US Securities Exchange Commission on February 12, 2014), the holders of Series E Preferred Stock will be limited to a maximum number of shares of the Issuer's common stock or other applicable consideration equal to 29 (the "Share Cap") multiplied by the number of shares of Series E Preferred Stock converted.

F2: The Series E Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption, and will remain outstanding indefinitely unless the Issuer repurchases, redeems or converts it into the Issuer's common stock in connection with a Change of Control or a Market Trigger (as defined in the Issuer's Prospectus as filed with the US Securities Exchange Commission on February 12, 2014), or unless the Reporting Persons choose to convert the Series E Preferred Stock into the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Series E Preferred Stock is convertible at any time at the option of the Reporting Persons into the number of whole shares of the Issuer's common stock which is equal to $25.00 per share, plus accrued and unpaid dividends, divided by a conversion price of $21.00. In the event of a change of control (as further described in the certificate of designation of rights and preferences for the Series E Preferred Stock, or Certificate of Designations, filed as Exhibit 3.11 to the Company's Form 8-A filed with the US Securities Exchange Commission on February 12, 2014), the holders of Series E Preferred Stock will be limited to a maximum number of shares of the Issuer's common stock or other applicable consideration equal to 29 (the "Share Cap") multiplied by the number of shares of Series E Preferred Stock converted.

F2: The Series E Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption, and will remain outstanding indefinitely unless the Issuer repurchases, redeems or converts it into the Issuer's common stock in connection with a Change of Control or a Market Trigger (as defined in the Issuer's Prospectus as filed with the US Securities Exchange Commission on February 12, 2014), or unless the Reporting Persons choose to convert the Series E Preferred Stock into the Issuer's common stock.

Bio Green Med Solution, Inc.

Report date April 24, 2020 · Filed May 05, 2020

Jointly reported with Eastern Capital LTD, Portfolio Services Ltd.

Section 16 reporting ended · disclosed 2020-05-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect65,863 Reported balance Holding disclosure · report date 2020-04-24 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 65,863

F1: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024. The current holdings reflect adjustments for reverse stock split of the Issuer's common stock and warrant that was effected on April 14, 2020.

WarrantSEC Table II · derivative / convertible securityDirect1 Reported balance Holding disclosure · report date 2020-04-24 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 1

F1: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024. The current holdings reflect adjustments for reverse stock split of the Issuer's common stock and warrant that was effected on April 14, 2020.

Filing footnotes · ownership attribution and instrument terms

F1: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024. The current holdings reflect adjustments for reverse stock split of the Issuer's common stock and warrant that was effected on April 14, 2020.

Marker Therapeutics, Inc.

Report date November 09, 2020 · Filed November 13, 2020

Jointly reported with Eastern Capital LTD, Portfolio Services Ltd.

Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect4,050,001 Reported balance Holding disclosure · report date 2020-11-09 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 4,050,001

Series F-1 WarrantSEC Table II · derivative / convertible security · Expires 2021-08-11Direct1 Reported balance Holding disclosure · report date 2020-11-09 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 1

F1: Series F-1 Warrant is exercisable upon the date of issuance with an exercise price of $7.20 per share and expires on the five year anniversary of the date of issuance

Filing footnotes · ownership attribution and instrument terms

F1: Series F-1 Warrant is exercisable upon the date of issuance with an exercise price of $7.20 per share and expires on the five year anniversary of the date of issuance

iBio, Inc.

Report date August 07, 2020 · Filed August 11, 2020

Jointly reported with Eastern Capital LTD, Portfolio Services Ltd.

Section 16 reporting ended · disclosed 2020-08-11. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect33,114,597 Reported balance After 2020-08-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2020-08-07 · Conversion · Acquired 28,925,000 · Balance 33,114,597

F1: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

Common StockSEC Table I · non-derivativeDirect31,758,993 Reported balance After 2020-08-07 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2020-08-07 · Sale · Disposed 1,355,604 · Balance 31,758,993

F2: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.62 to $4.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Common StockSEC Table I · non-derivativeDirect24,494,129 Reported balance After 2020-08-10 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2020-08-10 · Sale · Disposed 7,264,864 · Balance 24,494,129

F3: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.65 to $4.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Common StockSEC Table I · non-derivativeDirect8,629,693 Reported balance After 2020-08-11 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2020-08-11 · Sale · Disposed 15,864,436 · Balance 8,629,693

F4: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $2.69 to $3.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request

Series B Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.20Direct0 Reported balance After 2020-08-07 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2020-08-07 · Conversion · Disposed 5,785 · Balance 0

F1: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F2: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.62 to $4.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F3: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.65 to $4.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F4: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $2.69 to $3.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 27, 2026 Filed Mar 31, 2026 22:06 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 297,648 $100.83 $30,012,294.31
Disclosure

SEC source: 0001331271-26-000022 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 7,751,066

Underlying: Common Stock · 297,648 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $100.8315 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i) the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on OBFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · balance_after: Lake Michigan Limited is the party to the reported transaction and direct "holder" of the "notional" shares. LBS Limited is a party to previously reported swap transactions that provide an aggregate position in 7,453,418 "notional" shares. As owner of Lake Michigan Limited and LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

F2 · ownership.nature: Lake Michigan Limited is the party to the reported transaction and direct "holder" of the "notional" shares. LBS Limited is a party to previously reported swap transactions that provide an aggregate position in 7,453,418 "notional" shares. As owner of Lake Michigan Limited and LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 18, 2026 Filed Mar 20, 2026 20:17 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 400,000 $108.41 $43,362,760.00
Disclosure

SEC source: 0001331271-26-000021 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 7,453,418

Underlying: Common Stock · 400,000 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $108.4069 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 21:59 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 340,864 $110.11 $37,532,603.21
Disclosure

SEC source: 0001331271-26-000020 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 7,053,418

Underlying: Common Stock · 340,864 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $110.1102 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 22:55 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 212,240 $108.87 $23,107,290.42
Disclosure

SEC source: 0001331271-26-000019 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,712,554

Underlying: Common Stock · 212,240 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $108.8734 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 21:22 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 245,936 $108.81 $26,759,656.73
Disclosure

SEC source: 0001331271-26-000015 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,500,314

Underlying: Common Stock · 245,936 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $108.8074 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 21:24 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 1,214,188 $109.87 $133,404,656.84
Disclosure

SEC source: 0001331271-26-000014 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,254,378

Underlying: Common Stock · 1,214,188 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $109.8715 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 21:41 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 802,080 $106.29 $85,253,243.62
Disclosure

SEC source: 0001331271-26-000013 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,040,190

Underlying: Common Stock · 802,080 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $106.2902 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 10, 2026 Filed Mar 12, 2026 22:05 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 843,712 $106.50 $89,852,796.86
Disclosure

SEC source: 0001331271-26-000012 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 4,238,110

Underlying: Common Stock · 843,712 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $106.4970 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 21:59 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 900,000 $108.87 $97,980,210.00
Disclosure

SEC source: 0001331271-26-000011 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 3,394,398

Underlying: Common Stock · 900,000 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $108.8669 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 22:56 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 846,685 $112.05 $94,867,328.84
Disclosure

SEC source: 0001331271-26-000010 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,494,398

Underlying: Common Stock · 846,685 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $112.0456 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 21:53 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 362,003 $113.27 $41,005,202.02
Disclosure

SEC source: 0001331271-26-000009 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,647,713

Underlying: Common Stock · 362,003 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $113.2731 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 22:12 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 113,233 $112.14 $12,697,654.21
Disclosure

SEC source: 0001331271-26-000008 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,285,710

Underlying: Common Stock · 113,233 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $112.1374 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 21:58 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 319,624 $104.34 $33,350,335.26
Disclosure

SEC source: 0001331271-26-000007 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,172,477

Underlying: Common Stock · 319,624 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $104.3424 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity: (i)the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 23:05 UTC Flutter Entertainment plc FLUT · Entity 1330 PurchaseTotal Return Swap · Derivative 852,853 $104.51 $89,133,969.73
Disclosure

SEC source: 0001331271-26-000006 · primary_doc.xml · derivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 852,853

Underlying: Common Stock · 852,853 shares

Expires 2028-03-02

F1 · derivative.exercise_price: The reference price for the Swap is $104.5127 per share. The Swap is scheduled to terminate on March 2, 2028, at which time the Swap will be cash-settled. Under the terms of the Swap, at maturity:(i) the Reporting Person will be obligated to pay to the counterparty any decrease in the market price of the referenced shares below the reference price, and (ii) the counterparty will be obligated to pay the Reporting Person any increase in the market price of the referenced shares above the reference price. The Swap requires the Reporting Person to pay monthly interest to the counterparty on the financing leg of the Swap at a rate based on SOFR. Additionally, the Reporting Person is entitled to receive payments from the counterparty equal to any dividends paid on the referenced shares during the term of the Swap.

F2 · ownership.nature: LBS Limited is the party to the Swap and direct "holder" of the "notional" shares. As owner of LBS Limited, Mr. Dart may be deemed to beneficially own the reported securities but disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Read SEC document
August 11, 2020 Filed Aug 11, 2020 17:08 UTC iBio, Inc. IBIO · Entity 6906 SaleCommon Stock 15,864,436 $2.92 $46,330,498.89
Disclosure

SEC source: 0001408408-20-000047 · ownership.xml · nonDerivative · entry 4

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,629,693

F4 · security: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $2.69 to $3.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request

F4 · price: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $2.69 to $3.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request

Read SEC document
August 10, 2020 Filed Aug 11, 2020 17:08 UTC iBio, Inc. IBIO · Entity 6906 SaleCommon Stock 7,264,864 $3.91 $28,429,592.29
Disclosure

SEC source: 0001408408-20-000047 · ownership.xml · nonDerivative · entry 3

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,494,129

F3 · security: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.65 to $4.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F3 · price: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.65 to $4.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 17:08 UTC iBio, Inc. IBIO · Entity 6906 ConversionSeries B Preferred Stock · Derivative 5,785 Not disclosed Strike: $0.20 Not disclosed
Disclosure

SEC source: 0001408408-20-000047 · ownership.xml · derivative · entry 5

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,925,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F1 · kind: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F1 · price: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F1 · derivative.exercise_date: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F1 · derivative.expiration_date: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 17:08 UTC iBio, Inc. IBIO · Entity 6906 SaleCommon Stock 1,355,604 $3.83 $5,185,591.98
Disclosure

SEC source: 0001408408-20-000047 · ownership.xml · nonDerivative · entry 2

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,758,993

F2 · security: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.62 to $4.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F2 · price: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $3.62 to $4.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 17:08 UTC iBio, Inc. IBIO · Entity 6906 ConversionCommon Stock 28,925,000 $0.20 $5,785,000.00
Disclosure

SEC source: 0001408408-20-000047 · ownership.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,114,597

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F1 · kind: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

F1 · price: On August 6, 2020 Eastern Capital Limited provided notice to the Issuer with effect on August 7, 2020 to convert the shares of Series B Preferred Stock ("Preferred Shares") into shares of Common Stock. The Preferred Shares were convertible into Shares at the option of the holder, at any time, at a conversion price equal to $0.20 per share. As a result, the Preferred Shares converted into 28,925,000 shares of Common Stock.

Read SEC document
August 06, 2020 Filed Aug 6, 2020 17:33 UTC iBio, Inc. IBIO · Entity 6906 SaleCommon Stock 2,768,137 $4.18 $11,570,535.85
Disclosure

SEC source: 0001408408-20-000039 · ownership.xml · nonDerivative · entry 3

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,114,597

F3 · security: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.05 to $4.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F3 · price: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.05 to $4.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Read SEC document
August 05, 2020 Filed Aug 6, 2020 17:33 UTC iBio, Inc. IBIO · Entity 6906 SaleCommon Stock 900,000 $4.46 $4,013,550.00
Disclosure

SEC source: 0001408408-20-000039 · ownership.xml · nonDerivative · entry 2

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,882,734

F2 · security: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.36 to $4.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F2 · price: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.36 to $4.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 17:33 UTC iBio, Inc. IBIO · Entity 6906 SaleCommon Stock 600,000 $4.39 $2,636,640.00
Disclosure

SEC source: 0001408408-20-000039 · ownership.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,782,734

F1 · security: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.31 to $4.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

F1 · price: The Price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.31 to $4.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the Issuer or a security holder of the Issuer upon request.

Read SEC document
June 16, 2020 Filed Jun 19, 2020 11:49 UTC Marker Therapeutics, Inc. MRKR · Entity 7609 OtherSeries E-1 Warrant · Derivative 416,667 Not disclosed Strike: $15.00 Not disclosed
Disclosure

SEC source: 0001408408-20-000029 · ownership.xml · derivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires 2020-06-16

F1 · security: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

F1 · date: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

F1 · shares: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

F1 · price: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

F1 · derivative.expiration_date: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

F1 · derivative.underlying: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

F1 · derivative.underlying_shares: The Series E-1 Warrant to purchase 416,667 shares of Common Stock of the Issuer at the exercise price of $15.00 per share with an expiration date of June 16, 2020, was not exercised by the Reporting Persons before such expiration.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:50 UTC Marker Therapeutics, Inc. MRKR · Entity 7609 OtherSeries A-1 Warrant · Derivative 416,667 Not disclosed Strike: $1.20 Not disclosed
Disclosure

SEC source: 0001408408-20-000011 · ownership.xml · derivative · entry 2

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 416,667 shares

Expires 2020-03-09

F1 · price: On February 18, 2020, Eastern Capital Limited exercised the Series A-1 Warrant with respect to 416,667 Warrant Shares at an exercise price of $1.20 per share and acquired an additional 416,667 shares of Common Stock.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:50 UTC Marker Therapeutics, Inc. MRKR · Entity 7609 OtherCommon Stock 416,667 $1.20 $500,000.40
Disclosure

SEC source: 0001408408-20-000011 · ownership.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,050,001

Read SEC document
March 14, 2019 Filed Mar 15, 2019 21:57 UTC iBio, Inc. IBIO · Entity 6906 OtherPreferred Stock 1 Not disclosed Not disclosed
Disclosure

SEC source: 0001408408-19-000014 · kbd-ibiof4032019.xml · nonDerivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Company

Disclosed balance after: 1

F1 · security: As of March 14, 2019, the Reporting Person indirectly owns 71.70% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · shares: As of March 14, 2019, the Reporting Person indirectly owns 71.70% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · price: As of March 14, 2019, the Reporting Person indirectly owns 71.70% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · balance_after: As of March 14, 2019, the Reporting Person indirectly owns 71.70% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

Read SEC document
March 14, 2019 Filed Jan 31, 2020 20:43 UTC Amendment iBio, Inc. IBIO · Entity 6906 OtherPreferred Stock 1 Not disclosed Not disclosed
Disclosure

SEC source: 0001408408-20-000003 · ownership.xml · nonDerivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Company

Disclosed balance after: 1

F1 · shares: The amendment is filed solely to reflect the Reporting Person's ownership interest being 72.71% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share.

F1 · price: The amendment is filed solely to reflect the Reporting Person's ownership interest being 72.71% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share.

F1 · balance_after: The amendment is filed solely to reflect the Reporting Person's ownership interest being 72.71% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 19:42 UTC iBio, Inc. IBIO · Entity 6906 OtherPreferred Stock 1 Not disclosed Not disclosed
Disclosure

SEC source: 0001408408-19-000007 · ownership.xml · nonDerivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Company

Disclosed balance after: 1

F1 · security: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · shares: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · price: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · balance_after: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

Read SEC document
July 12, 2018 Filed Jul 13, 2018 16:06 UTC iBio, Inc. IBIO · Entity 6906 PurchaseCommon Shares 2,200,000 $0.90 $1,980,000.00
Disclosure

SEC source: 0001408408-18-000018 · ecl_ibioform407112018.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,457,734

F1 · security: Eastern Capital Limited acquired 2,200,000 shares of common stock of the Issuer at a price of $0.90 per share as part of an underwritten public offering.

Read SEC document
June 26, 2018 Filed Jun 28, 2018 18:03 UTC iBio, Inc. IBIO · Entity 6906 PurchaseSeries B Preferred Shares · Derivative 5,785 $1,000.00 $5,785,000.00
Disclosure

SEC source: 0001408408-18-000014 · ecl_ibioform406282018.xml · derivative · entry 2

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,785

Underlying: Common Stock · 6,427,778 shares

Expires not disclosed

F2 · security: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

F2 · derivative.exercise_price: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

F1 · shares: Eastern Capital Limited acquired 1,683,334 shares of Common Stock of the Issuer (the "Shares") at a price of $0.90 per share and 5,785 Series B Preferred Shares at an offering price of $1,000 per Series B Preferred Share on June 26, 2018, in an underwritten public offering.

F2 · derivative.exercise_date: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

F2 · derivative.expiration_date: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

Read SEC document
June 26, 2018 Filed Jun 28, 2018 18:03 UTC iBio, Inc. IBIO · Entity 6906 PurchaseCommon Shares 1,683,334 $0.90 $1,515,000.60
Disclosure

SEC source: 0001408408-18-000014 · ecl_ibioform406282018.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,257,734

F1 · security: Eastern Capital Limited acquired 1,683,334 shares of Common Stock of the Issuer (the "Shares") at a price of $0.90 per share and 5,785 Series B Preferred Shares at an offering price of $1,000 per Series B Preferred Share on June 26, 2018, in an underwritten public offering.

Read SEC document
May 14, 2018 Filed May 16, 2018 21:28 UTC Marker Therapeutics, Inc. TPIV · Entity 7609 PurchaseCommon Stock 1,300,000 $2.40 $3,120,000.00
Disclosure

SEC source: 0001408408-18-000007 · ecl_tpivf4052018.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,300,002

F1 · security: On May 14, 2018, Eastern Capital Limited entered into a Common Stock Purchase Agreement with the Issuer to purchase 1,300,000 shares of common stock at a price per share of $2.40.

Read SEC document
November 30, 2017 Filed Dec 4, 2017 17:14 UTC iBio, Inc. IBIO US · Entity 6906 PurchaseCommon Stock 12,000,000 $0.20 $2,400,000.00
Disclosure

SEC source: 0001408408-17-000036 · ecl-ibiof412042017.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,744,000

Read SEC document
July 19, 2017 Filed Jul 21, 2017 21:37 UTC Bio Green Med Solution, Inc. CYCC · Entity 8225 PurchaseWarrant · Derivative 1 Not disclosed Strike: $2.00 Not disclosed
Disclosure

SEC source: 0001408408-17-000016 · cyccform4_07192017.xml · derivative · entry 2

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1

Underlying: Common Stock · 850,000 shares

Expires not disclosed

F1 · security: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.

F1 · date: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.

F1 · price: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.

F1 · derivative.exercise_date: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.

F1 · derivative.expiration_date: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.

Read SEC document
July 19, 2017 Filed Jul 21, 2017 21:37 UTC Bio Green Med Solution, Inc. CYCC · Entity 8225 PurchaseCommon Stock 850,000 $2.00 $1,700,000.00
Disclosure

SEC source: 0001408408-17-000016 · cyccform4_07192017.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,167,261

F1 · security: On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.

Read SEC document
February 23, 2017 Filed Feb 27, 2017 20:39 UTC iBio, Inc. IBIO · Entity 6906 PurchasePreferred Stock 1 Not disclosed Not disclosed
Disclosure

SEC source: 0001408408-17-000013 · ecl-ibio02232017.xml · nonDerivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Company

Disclosed balance after: 1

F1 · security: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

F1 · kind: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

F1 · price: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

F1 · ownership.nature: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.